Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein

Mitogen-activated protein kinases (MAPK) promote MAPK-activated protein kinase activation. In the MAPK pathway responsible for cell growth, ERK2 initiates the first phosphorylation event on RSK1, which is inhibited by Ca2+-binding S100 proteins in malignant melanomas. Here, we present a detailed in vitro biochemical and structural characterization of the S100B-RSK1 interaction. The Ca2+-dependent binding of S100B to the calcium/calmodulin-dependent protein kinase (CaMK)-type domain of RSK1 is reminiscent of the better known binding of calmodulin to CaMKII. Although S100B-RSK1 and the calmodulin-CAMKII system are clearly distinct functionally, they demonstrate how unrelated intracellular Ca2+-binding proteins could influence the activity of the CaMK domain-containing protein kinases. Our crystallographic, small angle x-ray scattering, and NMR analysis revealed that S100B forms a “fuzzy” complex with RSK1 peptide ligands. Based on fast-kinetics experiments, we conclude that the binding involves both conformation selection and induced fit steps. Knowledge of the structural basis of this interaction could facilitate therapeutic targeting of melanomas.

[1]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[2]  Maxim V. Petoukhov,et al.  New developments in the ATSAS program package for small-angle scattering data analysis , 2012, Journal of applied crystallography.

[3]  M. Gaestel,et al.  The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways , 2007, Nature Immunology.

[4]  T. Sturgill,et al.  Characterization of the p90 Ribosomal S6 Kinase 2 Carboxyl-terminal Domain as a Protein Kinase* , 2002, The Journal of Biological Chemistry.

[5]  K. Parris,et al.  Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme. , 2003, Structure.

[6]  A. Gavin,et al.  A MAP kinase docking site is required for phosphorylation and activation of p90rsk/MAPKAP kinase-1 , 1999, Current Biology.

[7]  P. Tompa,et al.  Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. , 2008, Trends in biochemical sciences.

[8]  Clive R. Bagshaw,et al.  Asymmetric Mode of Ca2+-S100A4 Interaction with Nonmuscle Myosin IIA Generates Nanomolar Affinity Required for Filament Remodeling , 2012, Structure.

[9]  David J Weber,et al.  S100 proteins in cancer , 2015, Nature Reviews Cancer.

[10]  Dmitri I. Svergun,et al.  Advanced ensemble modelling of flexible macromolecules using X-ray solution scattering , 2015, IUCrJ.

[11]  A. Fersht,et al.  Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53. , 2009, Journal of molecular biology.

[12]  David J Weber,et al.  The evolution of S100B inhibitors for the treatment of malignant melanoma. , 2013, Future medicinal chemistry.

[13]  Philippe P Roux,et al.  RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth , 2013, Oncogene.

[14]  Frank Wien,et al.  Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy , 2015, Proceedings of the National Academy of Sciences.

[15]  Philippe P Roux,et al.  Regulation and function of the RSK family of protein kinases. , 2012, The Biochemical journal.

[16]  Xianlong Gao,et al.  Localization and retention of p90 ribosomal S6 kinase 1 in the nucleus: implications for its function , 2012, Molecular biology of the cell.

[17]  R. Donato,et al.  S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK , 2006, Journal of cellular physiology.

[18]  Wen Hwa Lee,et al.  Structure of the CaMKIIδ/Calmodulin Complex Reveals the Molecular Mechanism of CaMKII Kinase Activation , 2010, PLoS biology.

[19]  Bernhard Rupp,et al.  Ten years of probabilistic estimates of biocrystal solvent content: new insights via nonparametric kernel density estimate. , 2014, Acta crystallographica. Section D, Biological crystallography.

[20]  David J Weber,et al.  Complex Formation between S100B Protein and the p90 Ribosomal S6 Kinase (RSK) in Malignant Melanoma Is Calcium-dependent and Inhibits Extracellular Signal-regulated Kinase (ERK)-mediated Phosphorylation of RSK* , 2014, The Journal of Biological Chemistry.

[21]  S. Gygi,et al.  The Tumor Suppressor DAP Kinase Is a Target of RSK-Mediated Survival Signaling , 2005, Current Biology.

[22]  Dan Wang,et al.  Comparative Analyses of the Three-dimensional Structures and Enzymatic Properties of α, β, γ, and δ Isoforms of Ca2+-Calmodulin-dependent Protein Kinase II* , 2004, Journal of Biological Chemistry.

[23]  Timothy L. Foley,et al.  Covalent Small Molecule Inhibitors of Ca2+-Bound S100B , 2014, Biochemistry.

[24]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[25]  Zigang Dong,et al.  Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2 , 2008, Nature Structural &Molecular Biology.

[26]  T. Fu,et al.  Structural basis for the autoinhibition of the C-terminal kinase domain of human RSK1. , 2012, Acta crystallographica. Section D, Biological crystallography.

[27]  R. Keller,et al.  The Computer Aided Resonance Assignment Tutorial , 2004 .

[28]  C. Heizmann,et al.  S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). , 2004, Biochemical and biophysical research communications.

[29]  S. Munshi,et al.  Crystal structures of the N‐terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors , 2007, Protein science : a publication of the Protein Society.

[30]  K. Griewank.  Biomarkers in melanoma , 2016, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[31]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[32]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[33]  Maria Deak,et al.  A phosphoserine/threonine‐binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation , 2002, The EMBO journal.

[34]  Philippe P Roux,et al.  Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases , 2011, Microbiology and Molecular Reviews.

[35]  Hagen Blankenburg,et al.  Specificity of Linear Motifs That Bind to a Common Mitogen-Activated Protein Kinase Docking Groove , 2012, Science Signaling.

[36]  D. Alessi,et al.  The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.

[37]  K. Kekesi,et al.  Crystal structure of the S100A4–nonmuscle myosin IIA tail fragment complex reveals an asymmetric target binding mechanism , 2012, Proceedings of the National Academy of Sciences.

[38]  Christopher J. Oldfield,et al.  Intrinsically disordered protein. , 2001, Journal of molecular graphics & modelling.

[39]  A. Reményi,et al.  Structural assembly of the signaling competent ERK2–RSK1 heterodimeric protein kinase complex , 2015, Proceedings of the National Academy of Sciences.

[40]  C. Heizmann,et al.  The crystal structures of human S100B in the zinc- and calcium-loaded state at three pH values reveal zinc ligand swapping. , 2011, Biochimica et biophysica acta.